期刊论文

中文

河南中医

1003-5028

2016

22

1

26-29

10.13862/j.cnki.cn43-1446/r.2016.01.008

(2013sk3079):湖南省科技厅项目 (No.12w000):湖南省教育厅项目 (No.2011SKl8):常德市科技局重点项目

本校为第一机构

目的：探讨新辅助化疗联合化癥回生片在中晚期宫颈癌治疗中的临床疗效与安全性。方法：将80例中晚期宫颈癌患者随机分为两组,每组40例,治疗组采取新辅助化疗联合化癥回生片口服进行治疗,对照组予单纯新辅助化疗。治疗结束后随访3年,评价两组患者近期临床疗效、3年后生存情况（3年生存率、局部复发率、远处转移率）、治疗前后肿瘤直径变化及不良反应发生率。结果：治疗组的临床总有效率为57.5%,明显高于对照组的35.0%,且与对照组比较,治疗组患者肿瘤直径缩小变化更明显,差异均有统计学意义（P〈0.05）;治疗组3年生存率为77.5%,显著高于对照组的52.5%,差异有统计学意义（P〈0.05）;而两组患者不良...

Objective： To explore the efficacy and safty of neoadjuvant chemotherapy（NACT） combined with Huazheng Huisheng tablets in the treatment of cervical cancer. Methods： The 80 patients with advanced cervical carcinoma were randomly assigned to treatment and control groups, 40 case in each. Patients were treated with neoadjuvant chemotherapy combined with Huazheng Huisheng tablets in treatment groups, and just theneoadjuvant chemotherapy treatment in control group. The patients were seen for follow-up visits for 3years after the treatment, and S...